| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 514,3 k € | -16.6% | 616,5 k € | -45.9% | 1,1 M € | +8.2% | 1,1 M € | -4.3% | 1,1 M € | +12.4% | 978,6 k € | +23.6% | 792,0 k € | -15.8% | 940,6 k € | +33.5% | 704,8 k € | -0.1% | 705,4 k € | +19.2% | 592,0 k € | +24.8% | 474,5 k € | -14.0% | 551,9 k € | +21.1% | 455,7 k € | -0.2% | 456,6 k € | +50.5% | 303,3 k € | +138.9% | 127,0 k € | |
| EBITDA | 139,6 k € | +14.8% | 121,6 k € | -70.0% | 405,5 k € | -5.9% | 430,7 k € | -15.6% | 510,4 k € | +25.0% | 408,2 k € | +20.1% | 339,9 k € | -19.5% | 421,9 k € | +76.2% | 239,5 k € | -17.9% | 291,6 k € | +3.1% | 282,9 k € | +53.3% | 184,5 k € | -26.8% | 252,1 k € | +39.3% | 181,0 k € | -10.7% | 202,7 k € | +15.3% | 175,9 k € | +59.9% | 110,0 k € | |
| Operating profit | 108,9 k € | +18.4% | 92,0 k € | -75.2% | 370,3 k € | -6.9% | 397,9 k € | -14.6% | 465,8 k € | +24.5% | 374,2 k € | +21.1% | 308,9 k € | -21.0% | 391,0 k € | +88.9% | 206,9 k € | -22.3% | 266,5 k € | +7.5% | 247,9 k € | +103.8% | 121,7 k € | -46.4% | 227,0 k € | +48.9% | 152,4 k € | -16.6% | 182,8 k € | +12.9% | 161,9 k € | +54.2% | 105,0 k € | |
| Profit/loss | 84,5 k € | +46.8% | 57,5 k € | -78.5% | 268,1 k € | -7.7% | 290,5 k € | -14.3% | 338,9 k € | +23.4% | 274,7 k € | +30.3% | 210,8 k € | -20.0% | 263,4 k € | +106.8% | 127,4 k € | -25.2% | 170,4 k € | +12.8% | 151,1 k € | +94.1% | 77,8 k € | -46.8% | 146,3 k € | +50.0% | 97,5 k € | -14.2% | 113,7 k € | +12.9% | 100,6 k € | +49.3% | 67,4 k € | |
| Equity | 71,2 k € | +0.1% | 71,2 k € | +0.8% | 70,6 k € | +0.1% | 70,6 k € | +0.9% | 69,9 k € | -2.6% | 71,8 k € | +36.8% | 52,5 k € | +0.4% | 52,3 k € | -3.0% | 53,9 k € | +0.7% | 53,5 k € | -73.7% | 203,2 k € | +120.7% | 92,1 k € | +69.7% | 54,2 k € | +225.4% | 16,7 k € | +3.4% | 16,1 k € | +4.4% | 15,5 k € | +4.4% | 14,8 k € | |
| Total assets | 405,0 k € | -18.1% | 494,8 k € | -37.2% | 788,0 k € | +8.8% | 724,1 k € | +5.2% | 688,3 k € | +5.1% | 654,7 k € | +5.2% | 622,4 k € | +2.0% | 610,1 k € | -24.4% | 807,1 k € | +19.8% | 673,6 k € | +30.0% | 518,3 k € | -7.1% | 557,7 k € | +29.9% | 429,2 k € | +48.1% | 289,8 k € | +2.4% | 283,1 k € | +24.1% | 228,1 k € | +34.6% | 169,5 k € | |
| Cash | 238,7 k € | +7.8% | 221,5 k € | -46.8% | 416,5 k € | +7.8% | 386,3 k € | +29.9% | 297,4 k € | +5.0% | 283,3 k € | +63.8% | 173,0 k € | -46.0% | 320,3 k € | -27.7% | 442,9 k € | +15.8% | 382,4 k € | +77.6% | 215,3 k € | +12.2% | 192,0 k € | -35.1% | 295,9 k € | +198.1% | 99,3 k € | -22.9% | 128,7 k € | +58.7% | 81,1 k € | +3.7% | 78,2 k € | |
| Debts | 327,3 k € | -22.8% | 423,6 k € | -40.9% | 717,4 k € | +9.8% | 653,5 k € | +5.7% | 618,4 k € | +6.1% | 582,9 k € | +2.3% | 569,9 k € | +2.2% | 557,9 k € | -25.9% | 753,2 k € | +21.5% | 620,1 k € | +96.8% | 315,2 k € | -31.6% | 460,8 k € | +25.1% | 368,4 k € | +34.9% | 273,1 k € | +2.3% | 267,0 k € | +31.5% | 203,0 k € | +31.2% | 154,7 k € | |
| Staff | 5 | 6,3 | 9,1 | 9,4 | 8,9 | 8,9 | 10 | 10 | 8,9 | 8,3 | 6,2 | 5,5 | 5,8 | 5,4 | 5 | 1,9 | 0,1 | |||||||||||||||||
Public limited company · Ieper · incorporated on 01/04/2009 · 5,0 ETP
Public limited company profitable and well capitalised. Cash position rising (+7.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Ad Hoc Clinical is a Public limited company incorporated in 2009. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Ieper. It employs on average 5,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette